Patents : |  |
| US Patent No. | Title |
| 7402246 | Systems and methods using multiple solvents for the removal of lipids from fluids
|
| 7459531 | 50 Human secreted proteins
|
| 7459532 | Variants of the TRP channel family member, LTRPC3G
|
| 7465459 | Piroplasmid vaccine
|
| 7465568 | Essential fungal polynucleotides, polypeptides, and methods of use
|
| 7465707 | Methods of treatment with TR10 polypeptides
|
| 7479284 | Babesia canis vaccine
|
| 7482013 | Albumin fusion proteins
|
| 7482442 | HEMCM42 nucleic acids
|
| 7491508 | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
| 7498027 | Methods of treatment using human tumor necrosis factor receptor TR17 antibodies
|
| 7456256 | BGS 4
|
| 7449314 | Rapid thermal cycle processing methods and apparatus
|
| 7446189 | Nucleic acids encoding mutant human CD80 and compositions comprising the same
|
| 7411051 | Antibodies to HDPPA04 polypeptide
|
| 7417121 | Human G-protein coupled receptor, HGPRBMY39
|
| 7423057 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
| 7429646 | Antibodies to human tumor necrosis factor receptor-like 2
|
| 7435808 | Polynucleotides encoding novel adiponectin receptor variant, AdipoR2v2
|
| 7439229 | Cytokine activity regulator molecules from tick salivary glands
|
| 7439321 | Peptides for detection of antibody to Anaplasma phagocytophilum
|
| 7439333 | Vascular endothelial growth factor 2
|
| 7442532 | Essential fungal CaYLR100w polypeptides, and methods of use
|
| 7446176 | 12 human secreted proteins
|
| 7498298 | Monomethylvaline compounds capable of conjugation to ligands
|
| 7501123 | Human G-protein chemokine receptor (CCR5) HDGNR10
|
| 7572618 | Polynucleotides encoding novel PCSK9 variants
|
| 7572628 | Eukaryotic layered vector initiation systems
|
| 7575758 | Acaricidal compositions and methods of use thereof
|
| 7579324 | Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
| 7592010 | Albumin fusion proteins
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7598364 | Plasmid encoding canine BMP-7
|
| 7601377 | Method for treating liquid materials
|
| 7601745 | Heterocyclic NF-kB inhibitors
|
| 7569384 | Albumin fusion proteins
|
| 7569225 | Immunogenic lipopeptides comprising T-helper and B-cell epitopes
|
| 7566533 | Clinically intelligent diagnostic devices and methods
|
| 7504105 | Treatment using antibodies to cytokine receptor common gamma chain like
|
| 7504481 | TRP channel family member, LTRPC3 polypeptides
|
| 7507413 | Albumin fusion proteins
|
| 7507414 | Albumin fusion proteins
|
| 7507789 | Detection of Anaplasma platys
|
| 7521424 | Albumin fusion proteins
|
| 7531186 | Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz
|
| 7531517 | Inhibitors of cancer cell, T-cell and keratinocyte proliferation
|
| 7541434 | Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
|
| 7553816 | p-amidobenzylethers in drug delivery agents
|
| 7604814 | Method of removing ticks from the epidermal tissue of humans and other mammals
|
